ArticleJournal of experimental pharmacology2021

Pharmacokinetics and Safety of an Intravitreal Humanized Anti-VEGF-A Monoclonal Antibody (PRO-169), a Biosimilar Candidate to Bevacizumab.

Patricia Muñoz-Villegas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.